Mastering bladder paraganglioma for optimal treatment: a case report of robot-assisted surgery.
Angelo OrsiniSimone FerrettiFlavia TamborinoRossella CicchettiDavide CiavarellaBarbara SecciaRaffaella BasilicoAntonella ColasanteMichele MarchioniLuigi SchipsPublished in: Therapeutic advances in urology (2024)
Bladder paraganglioma is a rare neuroendocrine neoplasm, either functional or non-functional, arising from the urinary bladder. Functional variants present with catecholamine-related symptoms, while non-functional variants pose diagnostic challenges, mimicking urothelial carcinoma. Misdiagnosis risks underscore the importance of accurate identification for appropriate patient management. In this case, a 52-year-old man, diagnosed incidentally with hypertension and reported occasional post-micturition tachycardia, underwent abdominal ultrasound for known hepatic cyst follow-up, revealing an oval hypoechoic bladder mass. Initial consideration of bladder urothelial carcinoma prompted further investigation with contrast-enhanced CT scan and cystoscopy that confirmed extrinsic mass nature, and subsequent robotic-assisted partial cystectomy was performed. Histologically, the removed mass exhibited characteristic features of bladder paraganglioma. Postoperative recovery was uneventful, with resolution of post-micturition tachycardia at 1 month. Follow-up includes endocrinological evaluation and a 6-month CT scan. In conclusion, bladder paraganglioma should be considered in para-vesical mass differentials. This case highlights the importance of meticulous history collection, even in asymptomatic patients, the need for a multidisciplinary approach for accurate diagnosis and management of this rare condition, and the robotic approach as a viable option.
Keyphrases
- contrast enhanced
- robot assisted
- computed tomography
- spinal cord injury
- minimally invasive
- magnetic resonance imaging
- dual energy
- urinary tract
- magnetic resonance
- diffusion weighted
- ejection fraction
- high resolution
- newly diagnosed
- end stage renal disease
- patients undergoing
- copy number
- dna methylation
- gene expression
- prognostic factors
- risk assessment
- squamous cell carcinoma
- percutaneous coronary intervention
- low grade
- lymph node
- combination therapy
- catheter ablation
- diffusion weighted imaging
- quality improvement
- patient reported outcomes
- acute coronary syndrome
- sleep quality
- patient reported
- climate change
- drug induced